Europe Ecg Equipment Market Forecast 2023-2032

The Europe ECG equipment market growth is estimated to progress at a CAGR of 5.67% during the forecast period, 2023 to 2032. The aging population, the implementation of supportive government initiatives and policies aimed at addressing the high rates of deaths and morbidity due to heart conditions, and the rising healthcare burden of cardiovascular diseases (CVDs) are set to facilitate the region's market growth.

MARKET INSIGHTS

The United Kingdom, Italy, Spain, Belgium, Germany, France, Poland, and Rest of Europe are studied for the Europe ECG equipment market growth assessment. In Germany, the aging population is on the rise. As a result, the prevalence of cardiovascular diseases is also projected to increase since the elderly are more vulnerable to CVDs. Moreover, the most common reason for hospital stays is chronic heart failure, incurring high costs. As a result, ECG telemetry devices are estimated to minimize the cost of hospital stays in the country.

In Italy, CVD accounts for 37% of the total deaths. The country is also at high risk of stroke and hypertension. In addition, technological advancements in the healthcare sector have brought about considerable changes, which have further aided researchers in outlining such findings, leading to the development of new, hands-free ECG equipment.

One in every three people has major risk factors for cardiovascular disease in France, as per the Fondation de France, with CVDs evaluated to be the main reason for deaths. Furthermore, the country's demand for ECG equipment is driven by collaborations between domestic web service providers and favorable government policies on medical devices. Hence, these factors are set to propel the Europe ECG equipment market growth during the forecast period.

COMPETITIVE INSIGHTS

Key players operating in the market are: Welch Allyn, Schiller AG, ZOLL Medical Corporation, etc.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation caters to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 4822

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. PREVALENCE OF CARDIOVASCULAR DISEASES
- 3.1.2. INCREASING USAGE OF MONITORING DEVICES DUE TO RISING GERIATRIC POPULATION
- 3.1.3. GROWING HEALTHCARE SPENDING
3.2. KEY RESTRAINTS
- 3.2.1. INTENSE COMPETITION AMONG VENDORS
- 3.2.2. COMPLEX REIMBURSEMENT POLICIES REGARDING CARDIOVASCULAR DISEASES (CVD)

4. KEY ANALYTICS

4.1. KEY MARKET TRENDS
4.2. PORTER'S FIVE FORCES ANALYSIS
- 4.2.1. BUYERS POWER
- 4.2.2. SUPPLIERS POWER
- 4.2.3. SUBSTITUTION
- 4.2.4. NEW ENTRANTS
- 4.2.5. INDUSTRY RIVALRY
4.3. VALUE CHAIN ANALYSIS
4.4. KEY BUYING CRITERIA
4.5. REGULATORY FRAMEWORK

5. MARKET BY LEAD TYPE

5.1. SINGLE LEAD
5.2. 3-6 LEAD
5.3. 12-LEAD

6. MARKET BY PRODUCT

6.1. DIAGNOSTIC ECG SYSTEM
- 6.1.1. REST ECG SYSTEM
- 6.1.2. STRESS ECG SYSTEM
- 6.1.3. HOLTER ECG SYSTEM
6.2. MONITORING ECG SYSTEM
- 6.2.1. EVENT MONITORING
- 6.2.2. CONTINUOUS MONITORING
- 6.2.3. REMOTE MONITORING

7. MARKET BY SYSTEM

7.1. STATIONARY ECG SYSTEM
7.2. PORTABLE ECG SYSTEM
- 7.2.1. APPLICATIONS OF PORTABLE ECG SYSTEMS IN DIGITAL AND TELEHEALTH MARKET
  - 7.2.1.1. CASE STUDY- 1: DEVELOPMENT OF PORTABLE ECG DEVICES
  - 7.2.1.2. CASE STUDY- 2: TELECARDIOLOGY
  - 7.2.1.3. CASE STUDY- 3: USE OF WEARABLE DEVICES FOR AMBULATORY MONITORING
- 7.2.2. HANDHELD ECG SYSTEM
- 7.2.3. WEARABLE ECG SYSTEM
- 7.2.4. PEN ECG SYSTEM
- 7.2.5. OTHER PORTABLE ECG SYSTEMS

8. MARKET BY END-USER

8.1. HOSPITALS & CLINICS
8.2. HOME/AMBULATORY CARE
8.3. OTHER END-USERS

9. GEOGRAPHICAL ANALYSIS

9.1. EUROPE
- 9.1.1. MARKET SIZE & ESTIMATES
- 9.1.2. EUROPE ECG EQUIPMENT MARKET DRIVERS
- 9.1.3. EUROPE ECG EQUIPMENT MARKET CHALLENGES
- 9.1.4. KEY PLAYERS IN EUROPE ECG EQUIPMENT MARKET
- 9.1.5. COUNTRY ANALYSIS
  - 9.1.5.1. UNITED KINGDOM
  - 9.1.5.1.1. UNITED KINGDOM ECG EQUIPMENT MARKET SIZE & OPPORTUNITIES
  - 9.1.5.2. GERMANY
  - 9.1.5.2.1. GERMANY ECG EQUIPMENT MARKET SIZE & OPPORTUNITIES
  - 9.1.5.3. FRANCE
  - 9.1.5.3.1. FRANCE ECG EQUIPMENT MARKET SIZE & OPPORTUNITIES
  - 9.1.5.4. ITALY
  - 9.1.5.4.1. ITALY ECG EQUIPMENT MARKET SIZE & OPPORTUNITIES
  - 9.1.5.5. SPAIN
  - 9.1.5.5.1. SPAIN ECG EQUIPMENT MARKET SIZE & OPPORTUNITIES
  - 9.1.5.6. BELGIUM
  - 9.1.5.6.1. BELGIUM ECG EQUIPMENT MARKET SIZE & OPPORTUNITIES
  - 9.1.5.7. POLAND
  - 9.1.5.7.1. POLAND ECG EQUIPMENT MARKET SIZE & OPPORTUNITIES
  - 9.1.5.8. REST OF EUROPE
  - 9.1.5.8.1. REST OF EUROPE ECG EQUIPMENT MARKET SIZE & OPPORTUNITIES

10. COMPETITIVE LANDSCAPE

10.1. KEY STRATEGIC DEVELOPMENTS
- 10.1.1. MERGERS & ACQUISITIONS
- 10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 10.1.3. PARTNERSHIPS & AGREEMENTS
- 10.1.4. BUSINESS EXPANSIONS & DIVESTITURES
10.2. COMPANY PROFILES
- 10.2.1. BIONET CO LTD
- 10.2.2. BIOTELEMETRY INC
- 10.2.3. COMPUMED INC
- 10.2.4. GE HEALTHCARE
- 10.2.5. HILL-ROM HOLDINGS INC
- 10.2.6. MCKESSON CORPORATION
- 10.2.7. MINDRAY MEDICAL INTERNATIONAL LIMITED
- 10.2.8. NIHON KOHDEN CORPORATION
- 10.2.9. PHILIPS HEALTHCARE
- 10.2.10. SCHILLER AG
- 10.2.11. SIEMENS HEALTHINEERS AG
- 10.2.12. SPACELABS HEALTHCARE (SUBSIDIARY OF OSI SYSTEMS INC)
- 10.2.13. WELCH ALLYN INC (ACQUIRED BY HILL-ROM)
- 10.2.14. ZOLL MEDICAL CORPORATION (ACQUIRED BY ASAHI KASEI)